-
A Novel Screening Method to Prioritise Cardiovascular Patients Receiving a Pharmaceutical Care Intervention and the Effects on Patients’ Difficulties with Managing Their Drug Treatment
28 Nov 2025 12:46 GMT
… pharmaceutical care intervention concerning the management of their drug treatment … , and ticagrelor. The … doctor.
Figure 3 Total difficulties with managing their drug treatment … medical knowledge showed difficulties with managing their drug treatment …
-
Comprehensive Report on the Atherosclerosis Drugs Market: Opportunities and Challenges
24 Nov 2025 10:30 GMT
… combination therapies, personalized treatment methods, telemedicine, …
• Bayer AG
• Janssen Pharmaceuticals Inc.
• Novartis AG
… Anti-Platelet Medications: Aspirin, Clopidogrel, Ticagrelor
2) … By Cholesterol Lowering Medication: Statins, PCSK9 Inhibitors, …
-
Prasugrel Beats Ticagrelor After PCI in High-Risk Diabetes
20 Nov 2025 09:49 GMT
… Bangalore, MD, professor of medicine at NYU Grossman School of … Medicine in New York City.
… trial was designed first to try to show noninferiority of ticagrelor … The TUXEDO-2 trial was funded by Sahajanand Medical Technologies (a …
-
Influence of Potential Pharmacodynamic Drug Interactions in Pharmacotherapy of Coronary Heart Disease with Comorbid Conditions on Treatment Adherence: A Cross-Sectional Study of a Ukrainian Patient Cohort
14 Nov 2025 21:28 GMT
… antidepressant medicines. The distribution of the number of drugs … 001]);
ASC with ticagrelor (31.03% [95% … addition to DAPT, statin therapy of varying intensity … Single-pill combination to improve hypertension treatment: pharmaceutical industry development …
-
Comparative study finds higher rates of adverse events with ticagrelor
11 Nov 2025 04:46 GMT
… of treatment with either of two strong blood-thinning medications—ticagrelor and … diabetes and multivessel disease. The trial focused on stent selection, revascularization … percutaneous coronary intervention with two drug-eluting stents in patients with …
-
Prasugrel shows advantage over ticagrelor in diabetic patients after stent placement
11 Nov 2025 04:06 GMT
… be an advantage to treatment with prasugrel over ticagrelor, and importantly, the … percutaneous coronary intervention with two drug-eluting stents in patients with … health status.
The medication comparison analysis in the trial followed these patients …
-
Landmark Indian trial Tuxedo-2 favours Prasugrel over Ticagrelor in high-rise diabetic patients after stunting
10 Nov 2025 19:43 GMT
… a Late-Breaking Clinical Trial at the American Heart … following the placement of drug-eluting stents.
Addressing a … between Ticagrelor and Prasugrel has remained debatable, with previous trials … once-a-day medication, compared to Ticagrelor which must be …
-
Alembic gets FDA final nod for ticagrelor tablets
30 Oct 2025 01:58 GMT
-
Alembic Pharmaceuticals receives US FDA final approval for ticagrelor tablets, 60 mg
29 Oct 2025 10:05 GMT
… & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) ticagrelor tablets, … drug (RLD), Brilinta tablets, 60 mg, of AstraZeneca Pharmaceuticals LP (AstraZeneca). Ticagrelor … who have been stented for treatment of ACS; to reduce …
-
Young cardiologists turn to AI for treatment of heart disease
22 Sep 2025 03:18 GMT
… helping doctors detect heart problems at an earlier stage, personalise treatments, … used medicines in heart attack patients undergoing stent procedures — ticagrelor and … financial incentives to boost drug sales, pharmaceutical companies should invest in …
About
© 1995-2025